Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
0.622
|
0.58
|
0.622
|
0.58
|
|
|
|
|
|
|
0.588
|
0.567
|
0.588
|
0.567
|
|
|
|
|
|
|
0.595
|
0.566
|
0.595
|
0.585
|
|
|
|
|
|
|
0.542
|
0.542
|
0.577
|
0.571
|
|
|
|
|
|
|
0.506
|
0.488
|
0.506
|
0.488
|
|
|
|
|
|
|
0.495
|
0.495
|
0.496
|
0.496
|
|
|
|
|
|
|
0.502
|
0.4995
|
0.508
|
0.4995
|
|
|
|
|
|
|
0.4765
|
0.4765
|
0.485
|
0.485
|
|
|
|
|
|
|
0.504
|
0.474
|
0.504
|
0.481
|
|
|
|
|
|
|
0.487
|
0.479
|
0.4905
|
0.4815
|
|
|
|
|
Senzime AB develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. It operates in Europe and the United States.